TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center December 7, 2012
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001